Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by Hydroqcon Dec 14, 2021 6:52pm
115 Views
Post# 34230907

RE:RE:RE:RE:RE:Are we getting back to 30s CAD?

RE:RE:RE:RE:RE:Are we getting back to 30s CAD?
I don't care if you are flipping. It's a good stratgie if you know how to use it. I am not there yet.

Like most non flipping spculator of this stock, the wait of data is killing me.

Can you explain to me in what way this trial is bs. Because for what I see, compared to Merck and Pfizer trial, nothing wrong.

Revive is a tiny company but this could turn as to be an advantage. Like turning on a dime when it's needed. MF added viral load and omicron in the course of the trial. There is a parallel research trial being done at the UCSF by Dr Fahy on severe covid case. Our trial can benefit from that open label trial.


FDA is hesitating allowing EUA to Merck pill.
Pfizer pill is for severe case.

There is also place for a couple of pill maker.

And most of it, the Bucillamine molcule is acting as a possible treatement for long hauler covid.

Everyone should do their DD instead of taking advice from you or me.

Anxious to see the data
But
I don't see negativism
<< Previous
Bullboard Posts
Next >>